Preferred Label : Fluticasone-Salmeterol Drug Combination;
MeSH definition : A drug combination of fluticasone and salmeterol that is used as an inhaler formulation
to manage the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE.;
MeSH synonym : Fluticasone - Salmeterol; Fluticasone Salmeterol; Fluticasone-Salmeterol Combination; Combination, Fluticasone-Salmeterol; Fluticasone Salmeterol Combination; Drug Combination, Fluticasone-Salmeterol; Fluticasone Salmeterol Drug Combination;
CISMeF synonym : Fluticasone Propionate, Salmeterol Xinafoate Drug Combination; Combination, Fluticasone-Salmeterol Drug;
MeSH hyponym : Advair HFA; Advair Diskus; seretide; Advair; Fluticasone Propionate-Salmeterol Xinafoate Combination; Fluticasone Propionate Salmeterol Xinafoate Combination; Fluticasone Propionate-Salmeterol Drug Combination; Fluticasone Propionate Salmeterol Drug Combination; Fluticasone Propionate - Salmeterol Combination; Fluticasone Propionate Salmeterol Combination; Fluticasone Propionate-Salmeterol Xinafoate Drug Combination; Fluticasone Propionate Salmeterol Xinafoate Drug Combination; Fluticasone Propionate - Salmeterol Xinafoate; Fluticasone Propionate Salmeterol Xinafoate; Fluticasone Propionate - Salmeterol; Fluticasone Propionate Salmeterol;
Is substance : O;
Origin ID : D000068297;
UMLS CUI : C0939232;
ATC code(s)
- Allowable qualifiers
- CISMeF manual mappings
- Currated CISMeF NLP mapping
- Pharmacological action(s)
- Record concept(s)
- Semantic type(s)
- UMLS correspondences (same concept)
A drug combination of fluticasone and salmeterol that is used as an inhaler formulation
to manage the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
https://ansm.sante.fr/actualites/decision-du-05-08-2024-portant-modification-au-registre-des-groupes-hybrides-mentionne-a-larticle-l-5121-10-du-code-de-la-sante-publique
https://ansm.sante.fr/uploads/2024/08/06/20240806-registre-hybride-decision-aout-2024.pdf
2024
false
false
false
France
French
Fluticasone-Salmeterol Drug Combination
legislation, pharmacy
legislation
drug substitution
Fluticasone Propionate
drug combinations
salmeterol and fluticasone
fluticasone
---
https://www.has-sante.fr/jcms/p_3314516/fr/propionate-de-fluticasone/salmeterol-arrow-airmaster-salmeterol-/-fluticasone
2022
false
false
false
France
evaluation of the transparency committee
Fluticasone
Fluticasone-Salmeterol Drug Combination
propionate
propionates
Salmeterol
---
https://www.has-sante.fr/jcms/p_3299694/fr/propionate-de-fluticasone-salmeterol-biogaran-airmaster-salmeterol-/-propionate-de-fluticasone
2021
false
false
false
France
drug combinations
treatment outcome
insurance, health, reimbursement
Fluticasone-Salmeterol Drug Combination
administration, inhalation
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
Fluticasone Propionate
bronchodilator agents
glucocorticoids
adrenergic beta-2 receptor agonists
asthma
pulmonary disease, chronic obstructive
adult
adolescent
child
salmeterol and fluticasone
evaluation of the transparency committee
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69214519
2021
false
false
false
France
French
Fluticasone-Salmeterol Drug Combination
administration, inhalation
salmeterol and fluticasone
summary of product characteristics
package leaflet
bronchodilator agents
anti-inflammatory agents
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64541342
2021
false
false
false
France
French
administration, inhalation
bronchodilator agents
anti-inflammatory agents
salmeterol and fluticasone
Fluticasone-Salmeterol Drug Combination
summary of product characteristics
package leaflet
---
https://www.ema.europa.eu/en/medicines/human/EPAR/seffalair-spiromax
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
Fluticasone-Salmeterol Drug Combination
Fluticasone-Salmeterol Drug Combination
Fluticasone Propionate
Fluticasone Propionate
salmeterol and fluticasone
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
adult
adolescent
asthma
administration, inhalation
bronchodilator agents
bronchodilator agents
glucocorticoids
glucocorticoids
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
Fluticasone
Fluticasone
---
https://www.has-sante.fr/jcms/p_3299652/fr/propionate-de-fluticasone/salmeterol-mylan-salmeterol-/-propionate-de-fluticasone
2021
France
evaluation of the transparency committee
propionate
Salmeterol
Fluticasone Propionate
Fluticasone-Salmeterol Drug Combination
registries
---
https://www.ema.europa.eu/en/medicines/human/EPAR/bropair-spiromax
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
Fluticasone-Salmeterol Drug Combination
Fluticasone-Salmeterol Drug Combination
Fluticasone Propionate
Fluticasone Propionate
salmeterol and fluticasone
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
adult
adolescent
asthma
administration, inhalation
bronchodilator agents
bronchodilator agents
glucocorticoids
glucocorticoids
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
Fluticasone
Fluticasone
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64188732
2021
false
false
false
France
French
administration, inhalation
bronchodilator agents
anti-inflammatory agents
salmeterol and fluticasone
Fluticasone-Salmeterol Drug Combination
summary of product characteristics
package leaflet
---
https://www.has-sante.fr/jcms/p_3299688/fr/propionate-de-fluticasone/salmeterol-zentiva-salmeterol-/-propionate-de-fluticasone
2021
false
false
false
France
treatment outcome
insurance, health, reimbursement
Fluticasone-Salmeterol Drug Combination
bronchodilator agents
glucocorticoids
Fluticasone Propionate
administration, inhalation
asthma
salmeterol and fluticasone
adrenergic beta-2 receptor agonists
adult
child
adolescent
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
evaluation of the transparency committee
---
https://www.has-sante.fr/jcms/p_3107629/fr/salfluair-easyhaler
2019
false
false
false
France
Fluticasone-Salmeterol Drug Combination
insurance, health, reimbursement
treatment outcome
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
asthma
pulmonary disease, chronic obstructive
administration, inhalation
salmeterol and fluticasone
evaluation of the transparency committee
---
https://minerva-ebp.be/FR/Article/2101
2017
false
false
false
false
Belgium
French
critical appraisal or critical reading
pulmonary disease, chronic obstructive
indacaterol
indacaterol and glycopyrronium bromide
glycopyrrolate
Fluticasone-Salmeterol Drug Combination
bronchodilator agents
Chronic obstructive airways disease exacerbated
drug therapy, combination
comparative study
---
https://www.ema.europa.eu/medicines/human/EPAR/airexar-spiromax
2016
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Fluticasone-Salmeterol Drug Combination
Fluticasone Propionate
Fluticasone Propionate
drug approval
europe
drug interactions
pregnancy
breast feeding
salmeterol and fluticasone
pulmonary disease, chronic obstructive
asthma
bronchodilator agents
bronchodilator agents
glucocorticoids
glucocorticoids
Severe asthma (disorder)
adult
administration, inhalation
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
risk assessment
drug evaluation, preclinical
Fluticasone-Salmeterol Drug Combination
Fluticasone
Fluticasone
---
http://www.has-sante.fr/portail/jcms/c_2630429/fr/quelle-place-pour-les-associations-fixes-corticoide-/-beta-2-mimetique-de-longue-duree-d-action-dans-le-traitement-de-la-bronchopneumopathie-chronique-obstructive
2016
false
false
false
France
French
guidelines for drug use
pulmonary disease, chronic obstructive
drug combinations
formoterol and beclometasone
formoterol and budesonide
Budesonide, Formoterol Fumarate Drug Combination
administration, inhalation
Formoterol Fumarate
Fluticasone-Salmeterol Drug Combination
bronchodilator agents
salmeterol and fluticasone
vilanterol and fluticasone furoate
Fluticasone
vilanterol
beclomethasone
glucocorticoids
adrenergic beta-2 receptor agonists
treatment outcome
benzyl alcohols
chlorobenzenes
---
https://minerva-ebp.be/fr/article/615
false
false
minerva-ebm.be
Belgium
French
Fluticasone-Salmeterol Drug Combination
pulmonary disease, chronic obstructive
bronchodilator agents
drug combinations
administration, inhalation
treatment outcome
pulmonary disease, chronic obstructive
adrenergic beta-agonists
critical appraisal or critical reading
comparative study
---
https://www.ema.europa.eu/medicines/human/EPAR/Aerivio-Spiromax
2016
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Fluticasone-Salmeterol Drug Combination
Fluticasone Propionate
Fluticasone Propionate
drug approval
europe
drug interactions
pregnancy
breast feeding
salmeterol and fluticasone
pulmonary disease, chronic obstructive
asthma
bronchodilator agents
bronchodilator agents
glucocorticoids
glucocorticoids
Severe asthma (disorder)
adult
administration, inhalation
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
risk assessment
drug evaluation, preclinical
Fluticasone-Salmeterol Drug Combination
Fluticasone
Fluticasone
---
http://www.has-sante.fr/portail/jcms/c_2585420/fr/airflusal-forspiro
http://www.has-sante.fr/portail/jcms/c_2585420/fr/airflusal-forspiro-fluticasone/-salmeterol-corticoide-/beta-2-mimetique
2015
false
false
false
false
France
French
evaluation of the transparency committee
administration, inhalation
treatment outcome
insurance, health, reimbursement
asthma
pulmonary disease, chronic obstructive
drug combinations
salmeterol and fluticasone
Fluticasone-Salmeterol Drug Combination
Fluticasone-Salmeterol Drug Combination
glucocorticoids
bronchodilator agents
adrenergic beta-2 receptor agonists
guidelines for drug use
---
http://www.has-sante.fr/portail/jcms/c_2018294/fr/quelle-place-pour-les-associations-fixes-corticoide-/-beta-2-mimetique-longue-duree-daction-dans-le-traitement-de-fond-de-lasthme-persistant
2015
false
true
false
France
French
treatment outcome
administration, inhalation
anti-asthmatic agents
asthma
persistent asthma
Moderate persistent asthma (disorder)
Severe persistent asthma (disorder)
practice guideline
guidelines for drug use
formoterol and beclometasone
adrenergic beta-2 receptor agonists
beclomethasone
glucocorticoids
salmeterol and fluticasone
anti-inflammatory agents
budesonide
formoterol and budesonide
formoterol and fluticasone
anti-asthmatic agents
costs and cost analysis
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
Budesonide, Formoterol Fumarate Drug Combination
Fluticasone-Salmeterol Drug Combination
---
http://www.has-sante.fr/portail/jcms/c_2585426/fr/salmeson
2015
false
France
French
Fluticasone-Salmeterol Drug Combination
adrenergic beta-agonists
bronchodilator agents
asthma
pulmonary disease, chronic obstructive
adult
child
treatment outcome
insurance, health, reimbursement
androstadienes
salmeterol and fluticasone
administration, inhalation
evaluation of the transparency committee
---
http://www.cochrane.org/fr/CD004106
2012
false
United Kingdom
France
French
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
Fluticasone-Salmeterol Drug Combination
Budesonide, Formoterol Fumarate Drug Combination
salmeterol and fluticasone
formoterol and budesonide
meta-analysis
asthma
chronic disease
adult
child
anti-inflammatory agents
bronchodilator agents
glucocorticoids
treatment outcome
french abstract
Asthma chronic
Childhood asthma (disorder)
---
http://www.has-sante.fr/portail/display.jsp?id=c_460217
http://www.has-sante.fr/portail/jcms/c_1340462/seretide-seretide-diskus
http://www.has-sante.fr/portail/jcms/c_1341954/seretide-18072012-ct8857
2012
false
France
French
corticosteroid therapy
Fluticasone-Salmeterol Drug Combination
adrenergic beta-agonists
bronchodilator agents
asthma
pulmonary disease, chronic obstructive
adult
child
treatment outcome
insurance, health, reimbursement
drug combinations
salmeterol and fluticasone
administration, inhalation
evaluation of the transparency committee
---
http://www.lecrat.eu/?s=S%C3%A9r%C3%A9tide
2009
false
France
French
Fluticasone-Salmeterol Drug Combination
pregnancy
anti-asthmatic agents
breast feeding
salmeterol and fluticasone
drug information
---
http://www.has-sante.fr/portail/jcms/c_817349/seretide-diskus
http://www.has-sante.fr/portail/jcms/c_1263712/seretide-diskus-ct-5503-version-anglaise
2009
false
France
French
English
Fluticasone-Salmeterol Drug Combination
administration, inhalation
pulmonary disease, chronic obstructive
salmeterol and fluticasone
adult
treatment outcome
insurance, health, reimbursement
bronchodilator agents
evaluation of the transparency committee
comparative study
---
http://www.has-sante.fr/portail/jcms/c_818014/seretide-diskus-ct-5503
http://www.has-sante.fr/portail/jcms/c_844465/seretide-diskus-500/50-g/dose-fluticasone/salmeterol-corticoide-et-bronchodilatateur-de-longue-duree-d-action
2009
false
France
French
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
Fluticasone-Salmeterol Drug Combination
pulmonary disease, chronic obstructive
administration, inhalation
glucocorticoids
bronchodilator agents
adrenergic beta-agonists
treatment outcome
salmeterol and fluticasone
evaluation of the transparency committee
guidelines for drug use
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61572165
2008
false
France
French
corticosteroid therapy
Fluticasone-Salmeterol Drug Combination
Fluticasone-Salmeterol Drug Combination
adrenergic beta-agonists
bronchodilator agents
anti-inflammatory agents
drug interactions
administration, inhalation
pregnancy
drug approval
drug labeling
asthma
powders
pulmonary disease, chronic obstructive
drug combinations
salmeterol and fluticasone
summary of product characteristics
package leaflet
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61073237
2008
false
France
French
Fluticasone-Salmeterol Drug Combination
Fluticasone-Salmeterol Drug Combination
suspensions
bronchodilator agents
adrenergic beta-agonists
drug interactions
pregnancy
drug approval
administration, inhalation
drug labeling
drug combinations
salmeterol and fluticasone
summary of product characteristics
package leaflet
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67546191
2008
false
France
French
Fluticasone-Salmeterol Drug Combination
adrenergic beta-agonists
bronchodilator agents
asthma
pulmonary disease, chronic obstructive
drug approval
administration, inhalation
drug labeling
pregnancy
drug interactions
powders
drug combinations
salmeterol and fluticasone
summary of product characteristics
package leaflet
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64587838
2008
false
France
French
Fluticasone-Salmeterol Drug Combination
Fluticasone-Salmeterol Drug Combination
suspensions
bronchodilator agents
adrenergic beta-agonists
drug combinations
asthma
drug approval
administration, inhalation
drug labeling
drug interactions
pregnancy
salmeterol and fluticasone
summary of product characteristics
package leaflet
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69505268
2008
false
France
French
Fluticasone-Salmeterol Drug Combination
Fluticasone-Salmeterol Drug Combination
drug combinations
drug interactions
suspensions
bronchodilator agents
adrenergic beta-agonists
asthma
drug approval
drug labeling
administration, inhalation
pregnancy
salmeterol and fluticasone
summary of product characteristics
package leaflet
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60569419
2008
false
France
French
Fluticasone-Salmeterol Drug Combination
Fluticasone-Salmeterol Drug Combination
powders
bronchodilator agents
drug combinations
drug interactions
pregnancy
drug approval
drug labeling
administration, inhalation
adrenergic beta-agonists
asthma
pulmonary disease, chronic obstructive
salmeterol and fluticasone
package leaflet
summary of product characteristics
---
https://minerva-ebp.be/fr/article/598
2007
false
false
minerva-ebm.be
Belgium
French
Fluticasone-Salmeterol Drug Combination
Fluticasone
Salmeterol Xinafoate
Tiotropium Bromide
comparative study
bronchodilator agents
pulmonary disease, chronic obstructive
androstadienes
drug therapy, combination
treatment outcome
critical appraisal or critical reading
---
http://www.has-sante.fr/portail/display.jsp?id=c_400175
2005
false
France
French
Fluticasone-Salmeterol Drug Combination
administration, inhalation
adrenergic beta-agonists
bronchodilator agents
asthma
child
insurance, health, reimbursement
treatment outcome
salmeterol and fluticasone
evaluation of the transparency committee
---
https://minerva-ebp.be/fr/article/802
2005
false
false
minerva-ebm.be
Belgium
French
Fluticasone-Salmeterol Drug Combination
asthma
anti-asthmatic agents
leukotriene antagonists
quinolines
acetates
adult
bronchodilator agents
adrenergic beta-agonists
treatment outcome
asthma
montelukast
acetates
critical appraisal or critical reading
comparative study
---
https://www.cadth.ca/sites/default/files/pdf/321_combo_therapy_cetap_f.pdf
2005
false
Canada
French
corticosteroid therapy
Budesonide, Formoterol Fumarate Drug Combination
Fluticasone-Salmeterol Drug Combination
asthma
adult
anti-asthmatic agents
drug combinations
journal article
scientific and technical information
---
https://minerva-ebp.be/fr/article/810
2004
false
false
minerva-ebm.be
Belgium
French
corticosteroid therapy
Fluticasone-Salmeterol Drug Combination
pulmonary disease, chronic obstructive
bronchodilator agents
anti-inflammatory agents
adrenergic beta-agonists
treatment outcome
critical appraisal or critical reading
---
http://www.has-sante.fr/portail/display.jsp?id=c_399927
2004
false
France
French
Fluticasone-Salmeterol Drug Combination
powders
administration, inhalation
adrenergic beta-agonists
bronchodilator agents
insurance, health, reimbursement
treatment outcome
pulmonary disease, chronic obstructive
adult
salmeterol and fluticasone
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/display.jsp?id=c_399164
2001
false
France
French
Fluticasone-Salmeterol Drug Combination
bronchodilator agents
adrenergic beta-agonists
administration, inhalation
drug combinations
asthma
adult
insurance, health, reimbursement
treatment outcome
adolescent
salmeterol and fluticasone
evaluation of the transparency committee
---
